| Karen R Stolman, MD | |
|
1790 Sun Peak Dr Ste A103, Park City, UT 84098-6625 | |
| (435) 658-1013 | |
| Not Available |
| Full Name | Karen R Stolman |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 1790 Sun Peak Dr Ste A103, Park City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700997699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 52163981205 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Karen Stolman Md Pc | 5890197933 | 3 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
From August 28 through 30, 2019, Metrohm will be hosting the 3rd Global User Meeting IC in Herisau, Switzerland.
Black patients preoccupied with racial concerns have higher blood pressure than those who aren't, according to results of new Johns Hopkins-led research. The findings suggest that heightened race consciousness could at least in part account for the disproportionately high rate of hypertension in black Americans — the highest prevalence of any group in the United States and one of the highest rates in the world.
› Verified 9 days ago
| Entity Name | Dermatology Division University Of Utah Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922096114 PECOS PAC ID: 9638073497 Enrollment ID: O20031122000107 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
From August 28 through 30, 2019, Metrohm will be hosting the 3rd Global User Meeting IC in Herisau, Switzerland.
Black patients preoccupied with racial concerns have higher blood pressure than those who aren't, according to results of new Johns Hopkins-led research. The findings suggest that heightened race consciousness could at least in part account for the disproportionately high rate of hypertension in black Americans — the highest prevalence of any group in the United States and one of the highest rates in the world.
› Verified 9 days ago
| Entity Name | Karen Stolman Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235705716 PECOS PAC ID: 5890197933 Enrollment ID: O20210712001883 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
From August 28 through 30, 2019, Metrohm will be hosting the 3rd Global User Meeting IC in Herisau, Switzerland.
Black patients preoccupied with racial concerns have higher blood pressure than those who aren't, according to results of new Johns Hopkins-led research. The findings suggest that heightened race consciousness could at least in part account for the disproportionately high rate of hypertension in black Americans — the highest prevalence of any group in the United States and one of the highest rates in the world.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen R Stolman, MD Po Box 575, Helena, MT 59624-0575 Ph: (406) 439-0607 | Karen R Stolman, MD 1790 Sun Peak Dr Ste A103, Park City, UT 84098-6625 Ph: (435) 658-1013 |
News Archive
Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late clinical stage NBN-Pac formulations, namely IG-001 (Cynviloq) and IG-004 (a D-a-tocopheryl polyethylene glycol succinate (TPGS)-based paclitaxel formulation) at the annual Nanomedicine 2013 meeting in Barcelona, Spain (April 11th - 12th).
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
From August 28 through 30, 2019, Metrohm will be hosting the 3rd Global User Meeting IC in Herisau, Switzerland.
Black patients preoccupied with racial concerns have higher blood pressure than those who aren't, according to results of new Johns Hopkins-led research. The findings suggest that heightened race consciousness could at least in part account for the disproportionately high rate of hypertension in black Americans — the highest prevalence of any group in the United States and one of the highest rates in the world.
› Verified 9 days ago
Dr. Steven Mark Kern, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1790 Sun Peak Dr Ste A103, Park City, UT 84098 Phone: 435-658-1013 Fax: 435-658-3513 |